Skip to content

Prognostic Role of LA Strain in Acute Myocardial Infarction

Cardiac MRI Left Atrial Strain Associated With Ischemic Stroke in Patients With Acute Myocardial Infarction

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06408636
Acronym
CMR-MI
Enrollment
780
Registered
2024-05-10
Start date
2019-09-02
Completion date
2024-03-31
Last updated
2024-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation, Mortality, Myocardial Infarction, Acute, Stroke Ischemic

Keywords

cardiac magnetic resonance, myocardial infarction, atrial fibrillation, ischemic stroke

Brief summary

This is a single-center retrospective observational study in which we consecutively selected patients diagnosed with acute myocardial infarction from September 2019 to March 2024 at the Affiliated Hospital of Xuzhou Medical University. Inclusion criteria: 1. CMR was completed during all hospitalizations; 2. complete clinical data; 3. received continuous cardiac monitoring during hospitalization. Exclusion criteria: 1. unclear or non-compliant CMR images; 2. previous history of myocardial infarction; 3. malignant tumors diseases. Dedicated cardiovascular imaging software CVI42 (cvi42® version 5.13.5, Circle Cardiovascular Imaging, Canada) was used for image analysis. LA strain was obtained by cardiac MRI feature tracking. Patient prognosis was obtained through chart notes and telephone follow-up. Major events included atrial fibrillation, ischemic stroke, and all-cause mortality.

Interventions

OTHERCardiac MRI

All selected patients completed a cardiac magnetic resonance examination without other interventions.

Sponsors

The Affiliated Hospital of Xuzhou Medical University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* 1.CMR was completed during all hospitalizations; 2. complete clinical data; 3. received continuous cardiac monitoring during hospitalization.

Exclusion criteria

* 1.unclear or non-compliant CMR images; 2. previous history of myocardial infarction; 3. malignant tumors diseases.

Design outcomes

Primary

MeasureTime frame
Primary endpoint events included all-cause death, ischemic stroke, and atrial fibrillationAll patients were followed until March 31, 2024

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026